Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal
Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Funding (Mubadala), has accomplished the acquisition of insulin producer DiabTec, a subsidiary of Ras Al Khaimah-headquartered Julphar, for an undisclosed charge. ¬ Haymarket Media Restricted. All rights reserved. 👇Observe extra 👇 👉 bdphone.com 👉 ultractivation.com 👉 trainingreferral.com 👉 …
Mubadala-backed Kelix Bio seals MENA insulin manufacturing deal Read More »